Filing Flows › Materials › Ecovyst (ECVT)
Ecovyst (ECVT) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Ecovyst (ECVT) Q3 2026 earnings results →
Q3 2026 Revenue up 51% year over year to $309M · 6¢ of every $1 of revenue kept as net profit · operating margin 9.5%
Ecovyst made $309M in Q3 2026 (+51% Y/Y): Virgin sulfuric acid $163M, Regenerated sulfuric acid and treatment services $107M, Catalyst activation and sulfur dioxide & derivatives $39.0M. Operating margin 9.5%, net earnings $18.2M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $308.6M in Q3 2026, up 51% year over year and up 23% from the previous quarter. Virgin sulfuric acid was the largest line at 53% of revenue. Virgin sulfuric acid added $66.5M year over year (up 69%), 64% of the total change.
Gross margin was 19.0%, down 6.4 points from Q3 2025. Operating profit was $29.2M, a 9.5% margin (down 4.3 points year over year). Of the extra revenue versus Q3 2025, 1% reached operating profit, below the 14% margin then. Operating expenses grew 24% against revenue growth of 51%. The fastest-growing cost line was SG&A (+30%). Net earnings were $18.2M. The effective tax rate was 20.0%.
Operating cash flow was $25.2M (down 54% year over year), 139% of net earnings. Non-cash charges added back $22.8M of depreciation and amortization and $2.4M of share-based compensation. Working capital and other items used $18.1M. Capital expenditures of $27.9M exceeded it, leaving free cash flow of −$2.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 5, 2026 | $309M | +51% | 9.5% | $18.2M | $25.2M |
| Q2 2026 | 10-Q | Aug 6, 2026 | $250M | +42% | 7.7% | $7.9M | $34.3M |
| Q1 2026 | 10-Q | May 5, 2026 | $215M | +50% | 5.8% | $4.3M | $16.9M |
| Q4 2025 | 10-K | Feb 27, 2026 | $199M | +34% | 10.9% | $5.7M | $41.8M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $205M | +33% | 13.8% | −$79.3M | $55.3M |
| Q2 2025 | 10-Q | Aug 7, 2025 | $200M | +10% | 8.9% | $6.0M | $33.0M |
| Q1 2025 | 10-Q | May 2, 2025 | $162M | +1% | -0.6% | −$3.6M | $10.3M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Ecovyst
Ecovyst Inc. (“Ecovyst” or the “Company”), formerly PQ Group Holdings Inc., was incorporated in Delaware on August 7, 2015. We trace our roots to the late 1800s with our first sulfuric acid plant and the beginning of our oldest customer relationship. Our common stock is listed on the New York Stock Exchange under the stock ticker “ECVT”. Unless the context otherwise indicates, the terms “Ecovyst Inc.,” “we,” “us,” “our,” or the “Company” mean Ecovyst Inc. and our subsidiaries.
In its own words, from its 10-K, filed Feb 27, 2026.
Ecovyst against its Chemicals & Allied Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +51% against the peers' median +8%. Operating margin: 9.5% against the peers' median 9.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ECVT Ecovyst | Q3 2026 | $309M | +51% | 9.5% |
| OLN Olin | Q3 2026 | $1.7B | +2% | 3.4% |
| HUN Huntsman | Q3 2026 | $1.7B | +18% | 2.3% |
| Huntsman International LLC | Q2 2026 | $1.7B | +14% | 2.2% |
| CC Chemours | Q3 2026 | $1.5B | +3% | 14.4% |
| SOLS Solstice Advanced Materials | Q3 2026 | $1.0B | +8% | 10.7% |
| IOSP Innospec | Q3 2026 | $474M | +7% | 8.8% |
| PRM Perimeter Group | Q3 2026 | $390M | +24% | 106.8% |
| NGVT Ingevity | Q3 2026 | $305M | -8% | 22.0% |
Source: Ecovyst 10-Q on SEC EDGAR · CIK 1708035 · Chemicals & Allied Products
Guidance and outlook
13F: who owns ECVT and who is buying
More on ECVT
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results